MIR200B (microRNA 200b) by Xi, Yaguang & Chang, Hong
Gene Section 
Short Communication 
Atlas Genet Cytogenet Oncol Haematol. 2016; 20(5) 273 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
INIST-CNRS OPEN ACCESS JOURNAL 
MIR200B (microRNA 200b) 
Yaguang Xi, Hong Chang 
Mitchell Cancer Institute, University of South Alabama, USA. xi@health.southalabama.edu; 
hchang@health.southalabama.edu 
Published in Atlas Database: August 2015 
Online updated version : http://AtlasGeneticsOncology.org/Genes/MIR200BID51137ch1p36.html 
Printable original version : http://documents.irevues.inist.fr/bitstream/handle/2042/62776/08-2015-MIR200BID51137ch1p36.pdf 
DOI: 10.4267/2042/62776
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2016 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
Abstract 
Review on MIR200B, with data on RNA, and 
where it is implicated. 
Keywords 
MIR200B 
Identity 
HGNC (Hugo): MIR200B 
Location: 1p36.33 
Note 
MicroRNA 200b belongs to microRNA 200 family. 
MicroRNA 200 family consists of five microRNAs, 
microRNA 200b, microRNA 200a, microRNA 429, 
microRNA 200c and microRNA 141. MicroRNA 
200b, microRNA 200a and microRNA 429 were 
transcribed as a single ploycistronic transcript from 
chromosome 1. And microRNA 200 family were 
demonstrated important roles in EMT (epithelial-
mesenchymal transition) progress. 
DNA/RNA 
Description 
microRNA 200b located in chromosome 1 and 
microRNA 200b was transcribed with microRNA 
200a and microRNA 429 as a ploycistronic 
transcript. The putative transcription start site 
locates about 4228 bp upstream of the precursor of 
microRNA 200b. 
Transcription 
MiR-200b precursor: 5'-
CCAGCUCGGGCAGCCGUGGCCAUCUUACU
GGGCAGCAUUGGAUGGAGUCAGGUCUCUA
AUACUGCCUGGUAAUGAUGACGGCGGAGC
CCUGCACG-3' 
Mature miR-200b: 5'-
UAAUACUGCCUGGUAAUGAUGA-3' 
Pseudogene 
No pseudogene was found. 
MIR200B (microRNA 200b) Xi Y, Chang H 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2016; 20(5) 274 
 
Protein 
microRNAs are not translated into proteins. 
Implicated in 
Tumor cell proliferation 
Multiple roles of miR-200b in cell cycles regulation 
and tumor cell proliferation were reported in human 
cancers. MiR-200b could directly target RND3 
which could induce expression of cyclin D1 thereby 
promoting S-phase entry (Xia, Li et al. 2010). MiR-
200b could also regulate cell cycle by targeting 
GATA4 and its downstream protein cyclin D1 
which could affect cell proliferation (Yao, Wei et 
al. 2013). In human TGFBR2-null colorectal 
cancers, miR-200b could stimulate tumor growth 
by targeting CDKN1B (p27/kip1). It was also found 
that miR-200b could promoter cell proliferation by 
targeting p27/kip1 (Fu, Liu et al. 2014). 
Tumor cells invasion and cancer 
metastasis 
Abnormal expressions of miR-200b were found in 
various cancers, including breast cancer, colon 
cancer, nasopharyngeal carcinoma, urothelial 
carcinoma and prostate cancer. MiR-200b could 
directly targeting SUZ12 and ROCK2 thus inhibit 
cholangiocarcinoma tumourigenesis and metastasis 
(Peng, Jiang et al. 2013). In gastric carcinoma, 
miR-200b was found to target ZEB2 and thereby 
repress tumor cell invasion and migration 
(Kurashige, Kamohara et al. 2012). 
Repression of epithelial-
mesenchymal transition (EMT) 
EMT is an important pathological progression and 
studies revealed vital roles of miR-200b in EMT 
regulation. MiR-200b could inhibit TGFB1-induced 
epithelial-mesenchymal transition by targeting 
SMAD2 intestinal epithelial cells and SMAD2 
could repress expression of vimentin, which 
indicated regulation role of miR-200b on vimentin 
(Chen, Xiao et al. 2013). Also, the role of miR-
200b in EMT regulation was observed in EMT 
induced by transforming growth factor-beta1 in 
kidney proximal tubular cells by directly target the 
3'-UTR of fibronectin (Tang, Chen et al. 2013). 
Chemoresistance 
Chemoresistance is the main cause of tumor 
relapse. Ectopic expression of miR-200b could 
reduce the chemoresistance of cells by targeting 
BIM1 in human tongue cancer cells. In human lung 
adenocarcinoma cells, miR-200b could target E2F3 
to sensitize tumor cells to chemotherapy agents. 
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